BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-77@pharmaconomics
DTSTAMP:20260707T013848Z
DTSTART;VALUE=DATE:20270316
DTEND;VALUE=DATE:20270317
SUMMARY:TAK Phase 3 — TAK-755
DESCRIPTION:Phase 3 trial results for TAK-755 in Thrombotic Thrombocytopenic Purpura (TTP) are due Mar 16\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT04683003\n\nTrack it: https://pharmaconomics.com/e/77
URL:https://pharmaconomics.com/e/77
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TAK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR